More importantly, when correlated with clinical data, we found that p21, P-S6 or the combination of both proteins significantly associated with disease-specific survival in our cohort of patients with orolaryngeal, laryngeal and hypopharyngeal HNSCC. Here, TAS2R63P is linked to head and neck squamous cell carcinoma.